Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 36.7893.14298.54-62.910.46

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 36.78 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202536.78
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 36.78
-60.51
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹21,259.2 Cr 2.7% 8.7% 33.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,610.0 Cr -2.1% 13.6% 6.3% Stock Analytics
DIVIS LABORATORIES ₹179,279.0 Cr -2% 6.2% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,649.0 Cr 0.5% 8.2% 39% Stock Analytics
CIPLA ₹114,469.0 Cr 1.3% 9.5% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,955.0 Cr 0.6% 1% 8.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.7%

8.7%

33.9%

SENSEX

1.1%

-2.1%

-6.4%


You may also like the below Video Courses